Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Cabazitaxel in Platinum Pre-treated Transitional Cell Carcinoma
NCT01668459Phase 3Completed
- Start
- Jan 2013
- Primary completion
- Nov 2017
- Modality
- Lipid-based Nanoparticles, Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of cabazitaxel ginsenoside liposome injection in transitional cell carcinoma (TCC). Started Jan 2013; status: completed.
02
Drugs
cabazitaxel ginsenoside liposome injection
03
Conditions
transitional cell carcinoma (TCC)
Beyond the preview
Go deeper on NCT01668459.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01668459.